Syngen Biotech Co

Syngen Biotech Co EBIT per Share

The EBIT per Share of Syngen Biotech Co (8279.TWO) as of Nov 4, 2026 is 12.48 TWD. In the previous year, EBIT per Share was 11.45 TWD — a change of 8.99% (higher).

EBIT per Share

12.48TWD

YoY

8.99%

Last updated:

EBIT per Share of Syngen Biotech Co is 2025 12.48 TWD. EBIT per Share of Syngen Biotech Co was 2024 11.45 TWD. It decreases by 8.99% higher compared to the previous year.

The Syngen Biotech Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
7.01 TWD
Jan 1, 2019
10.10 TWD
Jan 1, 2020
9.55 TWD
Jan 1, 2021
11.01 TWD
Jan 1, 2022
14.79 TWD
Jan 1, 2023
12.59 TWD
Jan 1, 2024
11.45 TWD
Jan 1, 2025
12.48 TWD
The Syngen Biotech Co EBIT per Share history
YEAREBIT per ShareYoY
12.48TWD+8.99%
11.45TWD-9.09%
12.59TWD-14.88%
14.79TWD+34.35%
11.01TWD+15.23%
9.55TWD-5.41%
10.10TWD+44.07%
7.01TWD-3.72%
7.28TWD+36.57%
5.33TWD+29.48%
4.12TWD+103.58%
2.02TWD-1,418.21%
-0.15TWD-124.27%
0.63TWD-60.30%
1.59TWD-228.22%
-1.24TWD+54.95%
-0.80TWD-25.53%
-1.08TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Syngen Biotech Co Stock analysis

What does Syngen Biotech Co do? Syngen Biotech Co., Ltd. generates revenue through the manufacture and sale of microbial pharmaceuticals and biochemical nutrition products. The company's portfolio includes active pharmaceutical ingredients, health food raw materials, and animal health products. Additionally, the firm offers medical equipment such as bone density analyzers, blood glucose analyzers, and biochemical analyzers to its customer base. Syngen Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Syngen Biotech Co stock

EBIT per Share of Syngen Biotech Co is 12.48 TWD in 2025.

EBIT per Share of Syngen Biotech Co changed from 11.45 TWD to 12.48 TWD, representing a 8.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Syngen Biotech Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Syngen Biotech Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Syngen Biotech Co